KTTAW Pasithea Therapeutics Corp.
Fundamentals / CIK 0001841330 / USDPasithea Therapeutics Corp. reported $46.49M in total assets and a net loss of $24.83M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KTTAW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$27.82M Operating profit
-
Net Income FY 2025-$24.83M GAAP bottom line
-
Diluted EPS FY 2025-$0.74 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$41.22M Total debt: --
Annual revenue and net income
5 fiscal years (2021 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $487K | $15K |
| Cost of Revenue | -- | -- | -- | $113K | $17K |
| Gross Profit | -- | -- | -- | $373K | -$2.2K |
| Research & Development | $7.98M | $7.20M | $8.10M | $2.67M | -- |
| Selling, General & Admin | -- | $7.05M | $7.88M | $9.92M | $4.51M |
| Operating Income | -$20.86M | -$14.25M | -$15.98M | -$12.59M | -$4.51M |
| EBITDA | -$20.19M | -$13.60M | -$15.33M | -$12.58M | -$4.51M |
| Interest Income | $327K | $423K | $415K | -- | -- |
| Interest Expense | -- | -- | -- | $102 | $508 |
| Income Before Tax | -$20.43M | -$13.90M | -$15.51M | -$11.73M | -$2.17M |
| Net Income | -$20.43M | -$13.90M | -$15.96M | -$13.94M | -$2.17M |
| Basic EPS | -$2.91 | -$12.69 | -$0.42 | -$1.76 | -$0.21 |
| Diluted EPS | -$2.91 | -$12.69 | -$0.42 | -$1.76 | -$0.21 |
| Basic Shares Outstanding | 7.0M | 1.1M | 1.2M | 1.3M | 10.4M |
| Diluted Shares Outstanding | 7.0M | 1.1M | 1.2M | 1.3M | 10.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $4.46M | $3.69M | $2.94M | $2.74M | $1.36M | $2.15M | $1.73M | $1.51M |
| Operating Income | -$6.97M | -$5.71M | -$4.88M | -$10.26M | -$3.11M | -$3.81M | -$3.68M | -$3.26M |
| EBITDA | -- | -- | -- | -$10.10M | -$3.09M | -$3.65M | -$3.52M | -$3.10M |
| Interest Income | $371K | $410K | $450K | $182K | $43K | $54K | $47K | $80K |
| Income Before Tax | -$6.58M | -$5.27M | -$2.87M | -$10.11M | -$3.04M | -$3.72M | -$3.56M | -$3.18M |
| Net Income | -$6.58M | -$5.27M | -$2.87M | -$10.11M | -$3.04M | -$3.72M | -$3.56M | -$3.18M |
| Basic EPS | -$0.20 | -$0.16 | -$0.12 | -- | -$0.41 | -$0.66 | -$1.61 | -- |
| Diluted EPS | -$0.20 | -$0.16 | -$0.12 | -- | -$0.41 | -$0.66 | -$1.61 | -- |
| Basic Shares Outstanding | 33.4M | 32.1M | 24.3M | -- | 7.4M | 5.6M | 2.2M | -- |
| Diluted Shares Outstanding | 33.4M | 32.1M | 24.3M | -- | 7.4M | 5.6M | 2.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $55.16M | $6.92M | $16.33M | $33.09M | $52.97M | $244K |
| Cash & Short-Term Investments | $55.16M | $6.92M | $16.33M | $33.09M | $52.97M | $244K |
| Other Current Assets | $388K | $143K | $105K | $263K | -- | -- |
| Total Current Assets | $56.46M | $7.37M | $16.69M | $34.08M | $53.30M | $248K |
| Property, Plant & Equipment, Net | -- | $122K | $141K | $125K | $20K | -- |
| Goodwill | -- | $1.26M | $1.26M | $1.26M | -- | -- |
| Intangible Assets | $2.90M | $7.31M | $7.94M | $8.57M | -- | -- |
| Total Non-Current Assets | $3.78M | $8.70M | $9.42M | $11.10M | $20K | $0 |
| Total Assets | $60.24M | $16.06M | $26.12M | $45.18M | $53.32M | $248K |
| Total Current Liabilities | $4.97M | $1.12M | $2.63M | $1.88M | $447K | $6.6K |
| Total Non-Current Liabilities | $47K | $162K | $84K | $804K | $1.45M | $0 |
| Total Liabilities | $5.02M | $1.28M | $2.72M | $2.68M | $1.90M | $6.6K |
| Total Debt (incl. Leases) | -- | -- | $82K | $504K | -- | -- |
| Common Stock | $2.3K | $139 | $104 | $130 | $18K | $15K |
| Retained Earnings | -$70.01M | -$49.58M | -$35.32M | -$19.36M | -$2.21M | -$41K |
| Accumulated Other Comp. Income | $19K | -$7.2K | -$4.7K | -$661 | -$11K | -- |
| Total Stockholders' Equity | $55.22M | $14.78M | $23.40M | $42.50M | $51.42M | $241K |
| Total Equity | $55.22M | $14.78M | $23.40M | $42.50M | $51.42M | $241K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $41.22M | $45.66M | $50.40M | $55.16M | $4.12M | $7.22M | $5.34M | $6.92M |
| Cash & Short-Term Investments | $41.22M | $45.66M | $50.40M | $55.16M | $4.12M | $7.22M | $5.34M | $6.92M |
| Other Current Assets | $35K | $23K | $400K | $388K | $20K | $118K | $162K | $143K |
| Total Current Assets | $43.18M | $48.24M | $52.73M | $56.46M | $5.53M | $8.64M | $6.12M | $7.37M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | $114K | $118K | $122K |
| Goodwill | -- | -- | -- | -- | $1.26M | $1.26M | $1.26M | $1.26M |
| Intangible Assets | $3.31M | $3.47M | $3.62M | $2.90M | $6.84M | $7.00M | $7.15M | $7.31M |
| Total Non-Current Assets | $3.31M | $3.47M | $3.62M | $3.78M | $8.10M | $8.37M | $8.53M | $8.70M |
| Total Assets | $46.49M | $51.71M | $56.35M | $60.24M | $13.63M | $17.01M | $14.66M | $16.06M |
| Total Current Liabilities | $2.76M | $1.84M | $1.49M | $4.97M | $1.38M | $1.74M | $1.59M | $1.12M |
| Total Non-Current Liabilities | $0 | $32K | $53K | $47K | $47K | $94K | $85K | $162K |
| Total Liabilities | $2.76M | $1.87M | $1.54M | $5.02M | $1.42M | $1.83M | $1.68M | $1.28M |
| Common Stock | $3.3K | $3.3K | $2.5K | $2.3K | $743 | $743 | $270 | $139 |
| Retained Earnings | -$84.73M | -$78.15M | -$72.88M | -$70.01M | -$59.90M | -$56.86M | -$53.15M | -$49.58M |
| Accumulated Other Comp. Income | $48K | $9.6K | $47K | $19K | $18K | $5.6K | -- | -$7.2K |
| Total Stockholders' Equity | $43.73M | $49.84M | $54.80M | $55.22M | $12.21M | $15.18M | $12.98M | $14.78M |
| Total Equity | $43.73M | $49.84M | $54.80M | $55.22M | $12.21M | $15.18M | $12.98M | $14.78M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Net Income | -$20.43M | -$13.90M | -$15.96M | -$13.94M | -$2.17M |
| Depreciation & Amortization | $663K | $649K | $648K | $5.1K | $1.4K |
| Stock-Based Compensation | $297K | $774K | $592K | $835K | $471K |
| Operating Cash Flow | -$15.21M | -$13.92M | -$12.81M | -$14.56M | -$3.17M |
| Capital Expenditure | -- | -- | -$34K | -$107K | -$22K |
| Free Cash Flow | -- | -- | -$12.85M | -$14.67M | -$3.20M |
| Acquisitions, Net | -- | -- | -- | -$2.19M | -- |
| Investing Cash Flow | $11K | -- | $75K | -$2.06M | -$22K |
| Common Stock Issued | $2.08M | $4.52M | -- | -- | $1.21M |
| Share Repurchases | -- | -- | -$3.73M | -- | -- |
| Financing Cash Flow | $63.52M | $4.52M | -$3.73M | -$3.21M | $55.93M |
| Net Change in Cash | $48.34M | -$9.41M | -$16.76M | -$19.81M | $52.72M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.58M | -$5.27M | -$2.87M | -$10.11M | -$3.04M | -$3.72M | -$3.56M | -$3.18M |
| Depreciation & Amortization | -- | -- | -- | $158K | $24K | $161K | $162K | $162K |
| Stock-Based Compensation | $436K | $330K | $139K | $88K | $53K | $58K | $99K | $118K |
| Operating Cash Flow | -$4.48M | -$4.71M | -$4.79M | -$5.40M | -$2.89M | -$3.87M | -$3.06M | -$2.44M |
| Common Stock Issued | -- | -- | -- | $68K | $0 | $358K | $1.65M | -- |
| Financing Cash Flow | $0 | $8.5K | $750 | $56.42M | -$116K | $5.74M | $1.47M | -- |
| Net Change in Cash | -$4.45M | -$4.74M | -$4.76M | $51.04M | -$2.99M | $1.88M | -$1.58M | -$2.44M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | 76.7% | -14.7% |
| Operating Margin | -- | -- | -- | -2587.3% | -29925.7% |
| Net Profit Margin | -- | -- | -- | -2864.3% | -14430.5% |
| Return on Equity (ROE) | -37.0% | -94.1% | -68.2% | -32.8% | -4.2% |
| Return on Assets (ROA) | -33.9% | -86.6% | -61.1% | -30.8% | -4.1% |
| Current Ratio | 11.35x | 6.58x | 6.34x | 18.15x | 119.17x |
| Quick Ratio | 11.09x | 6.18x | 6.20x | 17.62x | 118.42x |
| Debt to Equity | -- | -- | 0.00x | 0.01x | -- |
| Revenue Growth (YoY) | -- | -- | -- | +3130.4% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -56.8% | -42.7% | -36.0% | -37.0% | -110.5% | -88.7% | -104.8% | -94.1% |
| Return on Assets (ROA) | -53.4% | -41.2% | -35.0% | -33.9% | -99.0% | -79.1% | -92.8% | -86.6% |
| Current Ratio | 15.67x | 26.25x | 35.40x | 11.35x | 4.02x | 4.97x | 3.84x | 6.58x |
| Quick Ratio | 14.96x | 24.85x | 33.84x | 11.09x | 2.99x | 4.15x | 3.35x | 6.18x |